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ABSTRACT: Among the predisposing factors to osteoarthritis (OA), a frequent destructive joint disease, is the complex genetic heritage
including the interleukin-1 familymembers like the IL1b (IL1B) and the IL1 receptor antagonist (IL1RN) genes. The aimof this studywas to
investigate allelic and genotypic frequencies of the IL1Bgene single nucleotide polymorphism (SNP) at511(G>A) and the variable number
tandemrepeat (VNTR) in the IL1RNgene in aCroatianCaucasianpopulationof hipOA(HOA) casesandhealthy controls. A total of 259HOA
patients with total hip replacement (THR) and 518 healthy blood donors as controls were genotyped for IL1B gene SNP511(G>A) and the
VNTR in the IL1RN gene associated with HOA. The genotype G/A (1/2) at IL1Bwas signiﬁcantly associated with the protection of the HOA
(p < 0.036,OR ¼ 0.72, 95%CI ¼ 0.52–0.99). The genotypeG/G (1/1) had only a trend towards the susceptibility (p ¼ 0.053,OR ¼ 1.35, 95%
CI ¼ 0.98–1.86) to disease.Noneof thehaplotypes IL1B511(G>A)and IL1RN(VNTR)were foundassociatedwith theHOA.Thehaplotype
1–2 at these loci had only a trend to susceptibility (p ¼ 0.065).Haplotype 1–3 had a signiﬁcantmale bias in diseased. Furthermore, genotype
comprising 2–1/2–2 haplotypes was found signiﬁcantly associatedwith predisposition to HOA (p ¼ 0.027, OR ¼ 2.23, 95%CI ¼ 1.03–4.88),
whereas genotype 1–1/2–2 with protection to disease (p ¼ 0.028, OR ¼ 0.65, 95% CI ¼ 0.43–0.97). Our ﬁndings suggest that HOA in
Croatian population might have a different genetic risk regarding the IL1 locus than has been reported for other Caucasian populations
previously.  2011 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29:1137–1144, 2011
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Osteoarthritis (OA) is the most frequent joint pathology
associated with health problems for middle aged and
older people. It is a debilitating, chronic, progressive,
and multifactorial disease of joints. It is important to
research into pathogenesis, clinical aspects, and treat-
ment of the disease because it has high incidence, preva-
lence and signiﬁcant medical, social and economic
inﬂuence on a society. Due to a wide clinical heterogen-
eity, it is unclear whether OA is a single disease or a mix
of distinct disorders regarding which tissues were prin-
cipally involved in the initiation and progression of the
disease. OA has two main types: (1) primary, with the
late onset and still uncertain cause, and (2) secondary,
which is distinguished by the early onset with the known
cause like developmental abnormalities, trauma, or the
like.1
The reasons for the development of the primary dis-
ease have not been completely understood and many
factors were implied to inﬂuence the risk of OA like
age, sex, genetics, ethnicity, behavioral inﬂuences,
obesity, and occupation.2,3 Concerning genetic linkage,
many family studies have suggested a complex
(polygenic) hereditary inﬂuence in predisposition to
OA.1,4–18 In particular, both sex-speciﬁc and anatomic
site-speciﬁc genes are likely to inﬂuence an individual’s
risk of developing OA. Furthermore, it is known that
complex genetic diseases might appear to be caused by
various genes in different populations. Several loci on
various chromosomeswere identiﬁed to date to be associ-
ated with disease, and thus thought to modify the risk to
OA. Four genome wide studies revealed several chromo-
somal loci linkedwith the disease (for a review see Peach
et al.1). One of them, interleukin-1 gene cluster on
chromosome 2q13, includes genes belonging to a func-
tional group of pro-inﬂammatory cytokines (IL1, TNF,
and IL6).19 However, a candidate gene approach would
also identify the IL1 family of pro-inﬂammatory genes as
a candidate in changing the risk for OA since the IL1
cytokine has been implicated in joint damage due to
stimulation of production of proteases that can degrade
the extracellular matrix proteins of cartilage.9
Several case/control genetic studies concerning
susceptibility to OA gave controversial results. The
IL1 gene cluster was found to be associated with knee
OA (but not with hip OA, HOA) in UK population.19 By
contrast, a study by Moos et al.20 analyzing IL1RN
variable number tandem repeat (VNTR) in total hip
replacement (THR) patients revealed a higher risk for
development of HOA, and Meulenbelt et al.21 corrobo-
rated that, albeit in radiographically diagnosed OA
(ROA) patients. However, Smith et al.22 showed that
OA of knee joints, but not of the hip, is associated with
IL1 gene cluster using additional polymorphic genetic
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markers within the cluster and combining them into
extended-risk haplotypes. A study by Moxley et al.23
showed that the extended-risk IL1 cluster haplotype
conferred a higher risk also for hand OA.
Frazer et al.24 noted that associations of the single
nucleotide polymorphism (SNP) identiﬁed in one popu-
lation are rarely transferable to members of the other
populations, if the risk is divided over a larger gene pool.
To ascertain this, we investigated the association to
primary HOA in Croatian Caucasians with a severe
HOA that have undergone THR using two polymorphic
markers for the IL1 region: IL1B (511G>A) and IL1RN
(VNTR).
PATIENTS AND METHODS
Subjects
The clinical criteria for admission to this case–control study
were the American College of Rheumatology (ACR) guidelines
for the classiﬁcation and reporting of HOA25 and Western
Ontario and McMaster Universities’ Osteoarthritis (WOMAC)
index to assess pain, joint stiffness and physical function in
patients with HOA.26 Indications for primary THR used in our
studywere according to theNational Institutes ofHealth (NIH)
Consensus Statement on THR, that include: joint pain, func-
tional limitation, and radiographic evidence of joint damage (in
our case: grade range 55–75, average 66).27 The study included
Croatian (259) patients with HOA (mean age ¼ 67.82 years,
standard deviation (SD) ¼ 9.61, range: 31–90). Control indi-
viduals were 518 blood donors (as; mean age ¼ 41.58 years,
SD ¼ 11.72, range: 19–91), who were healthy according to
criteria in admitting blood donors by the Department of Trans-
fusiology, University of Rijeka, Croatia. The consequences of
comparing such controls (some of whichmight developOA later
in life) with OA patients are that our results might be more
conservative. We excluded from the study patients with
primary HOA without indication for THR (i.e., less severe
OA) or assigned informed consent. Similarly, patients with
any secondary form of HOA and rheumatoid arthritis were
excluded too. The study was approved by the Medical ethics
committees of the Clinic for Orthopaedic Surgery Lovran, and
School of Medicine, University of Rijeka, Croatia.
Radiography and Interpretation
On the day of admission to the hospital, a supine anteroposte-
rior pelvic radiograph including both hips was obtained for
every patient included in the study using the same protocol.
Patient was positioned in the supine position on the X-ray table
with both lower extremities oriented in 158 of internal rotation.
The focus-to-ﬁlm distance was 100 cm. The X-ray beam was
oriented perpendicular to the table and centered approximately
2 cm above the superior aspect of the symphysis pubis. Each
radiograph was assessed for ﬁve individual radiographic fea-
tures (IRFs) ofHOA: (1)Kellgren–Lawrence (K/L) grading scale
(0–4),28 (2) superomedial and superolateral joint space narrow-
ing (JSN 0–4), (3) lateral (femoral and acetabular) and medial
(femoral and acetabular) osteophytes (for each location 0–3, for
all four locations 0–12), (4) subchondral cysts, sclerosis, and
femoral head deformity (0 for absent and 1 for present), and (5)
minimal joint space (MJS) from acetabular roof to the femoral
head using digital Vernier caliper. During the readings of
the radiographs, we were consulted atlas ﬁgures to improve
reliability.29 We assigned to each hip, based on IRFs,
a summary grade (modiﬁed Croft grade) for radiographic
HOA (RHOA) severity (0–4).30–32 We further characterized
all of our patients in three distinct RHOA phenotypes (compo-
site, osteophytic, and atrophic), according to previously
described phenotypic deﬁnitions for RHOA phenotypes.31 All
radiographs were evaluated by two experienced readers (BS
andRM) to reach consensus score. Intra-rater reliability for the
radiographic readings was evaluated from a random sample of
54 radiographs. The kappa coefﬁcients were for K/L grading
scale 0.92, forMJS0.87, for JSN inany location0.81, for deﬁnite
osteophytes in any location 0.69, and for summary grade 0.63.
DNA Isolation
For extraction of genomic DNA, 200 ml of whole blood was
mixed with 400 ml of sucrose buffer (0.32 M sucrose, 10 mM
Tris–HCl, pH 7.5, 5 mM MgCl2, 1%, v/v, Triton X-100) and
incubated for 1 min at room temperature. To collect white cell
nuclei, samples were centrifuged 2 min at 5,000g. Precipitated
nuclei were washed twice with 800 ml of sucrose buffer and
centrifuged (2 min at 5,000g). After the second wash the nuclei
were resuspended in 400 ml DNAzol (Invitrogen Corporation,
Carlsbad, CA) and incubated at room temperature for 5 min.
Genomic DNA was precipitated with 200 ml of 100% ethanol
and collected by centrifugation (2 min at 5,000g). The precipi-
tatewaswashed twicewith 1 ml of 75%ethanol and centrifuged
(1 min at 5,000g). Genomic DNA was resuspended in 100 ml of
8 mM NaOH and allowed to solubilize for 15 min at room
temperature. HEPES buffer (16 mM HEPES in 8 mM NaOH,
pH 7.5) was used to adjust the pH 7–8.4. The average concen-
tration of genomic DNA was 30 mg/ml with 260/280 OD ratio
higher than 1.7.
SNP Analysis
Allele discrimination assays were performed by the PCR
method. In short, the alleles of the IL1B gene at 511(G>A)
(rs16944) were detected by Taqman method using the primers
andprobe as reportedpreviously.33 The IL1 receptor antagonist
(IL1RN) VNTR were ampliﬁed by primers as described pre-
viously33 and thendetected by1.5%agarose gel electrophoresis.
The VNTR PCR detects variability in the repetition of 89
nucleotides in genomic DNA close to the IL1RN gene. The
individuals of Caucasian origin have one and four copies of
the repeats in 95% of cases. Their alleles were denoted as
follows: allele 1 ¼ 4 repeats; allele 2 ¼ 2 repeats; allele 3 ¼ 5
repeats, and allele 4 ¼ 3 repeats.
Statistical Analysis
Statistical analyses were done by chi-square method (Statcalc
program, Acastat software) comparing the allelic and genotypic
setup of the SNP loci between cases and controls. The assembly
and prediction of haplotypes for the IL1 cluster was done by
the software program ‘‘Phase.’’34,35 The Hardy–Weinberg and
linkage disequilibrium analyses for the SNP and VNTR was
assessed by the Arlequin software ver. 3.5 (Genetics and
Biometry Laboratory, University of Geneva, Geneva, Switzer-
land). These two loci were in the Hardy–Weinberg equilibrium
and were in linkage disequilibrium. A statistically signiﬁcant
difference was deﬁned when pwas<0.05, and a trend to associ-
ation and a signiﬁcant association were cases when statistical
signiﬁcance of a difference was approaching 0.05 (0.1–0.05) or
when p < 0.05 but 95% conﬁdence index (CI) limits spanned
values that crossed the value of 1. We did not use Bonferroni
correction because the two polymorphic markers were in link-
age disequilibrium (r2 > 0.83). This means that these two
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geneticmarkers are inherited as a block.Weused thehaplotype
analysis because the genetic area between these two loci har-
bors six more IL1- and IL1RN-like genes.
RESULTS
Table 1 summarizes frequencies of allelic/genotypic var-
iants of the IL1b (IL1B) and the IL1 receptor antagonist
(IL1RN) genes in our case–control study. Statistical
analysis was done by comparison of the frequencies in
the healthy blood donor groupwith those of patients that
have surgically replaced their hip joint.
In the Table 1, allelic frequencies for IL1B SNP
511(G>A) do not differ between patients and controls.
However, the genotype frequencies for G/A (1/2) at IL1B
was signiﬁcantly associated with the protection of the
HOA in Croatian population (p ¼ 0.036) with odds ratio
(OR) ¼ 0.72 and 95% CI limits ¼ 0.52–0.99. However,
the homozygous genotype G/G showed only a trend
to signiﬁcant difference (p ¼ 0.053, Table 1) and did
not convincingly support association. A similar analysis
of IL1RN VNTR locus showed differences between
patient and control populations that were not statisti-
cally signiﬁcant (Table 1).
As presented in Table 2, the frequencies of various
haplotypes comprising IL1B 511(G>A) and IL1RN
(VNTR) differ slightly among controls and patients,
but none of them were found statistically signiﬁcant.
Despite a ﬁnding that a haplotype 1–2 showed a trend
towards signiﬁcance (p ¼ 0.065), the two marker combi-
nation haplotype analysis revealed no association with
the HOA in this population.
However, as shown in Table 3, a genotype comprising
2–1/2–2 haplotypes were found signiﬁcantly associated
with predisposition to HOA with p ¼ 0.026 (OR ¼ 2.23,
95% CI ¼ 1.03–4.88). Interestingly, another genotype
(1–1/1–1) was found statistically signiﬁcantly different
between cases and controls with p ¼ 0.047, but due to
large 95%CI limits (0.99–1.97) it was considered a trend,
and thus not signiﬁcantly associatedwith predisposition
to OA (Table 3). Similarly, a genotype 1–2/1–2 was also
found to have a trend toward statistically signiﬁcant
difference between cases and controls (p ¼ 0.06). Impor-
tantly, a genotype 1–1/2–2 was signiﬁcantly associated
with protection to disease (p ¼ 0.028, OR ¼ 0.65, 95%
CI ¼ 0.43–0.97).
The analysis for gender differences revealed great
variations at genotypic (Table 4) and haplotypic levels
(Table 5).
Genotypes 1–1/1–3 and 1–1/2–1 were signiﬁcantly
associated with a bias to higher incidence of OA in either
males (p < 0.04, OR ¼ 0.11, 95% CI ¼ 0.00–1.19) or
females (p < 0.03, OR ¼ 2.45, 95% CI ¼ 1.05–6.41),
respectively (Table 5).
The haplotype 1–3 (Table 5) was signiﬁcantly associ-
ated with a bias towards male population in acquiring
HOA (p ¼ 0.006, OR ¼ 0.13, 95% CI ¼ 0.01–0.70).
Considering radiographic features and radiographic
phenotypes of HOApatients, all of our patients have aK/
L score of 3, superomedial and superolateral JSN was
2 (>90% of our patients had a JSN score of 3 or 4 in
one of both locations), overall osteophytes score in all
four locations was >8, and MJS was <1 mm (average
0.92 mm). Regarding the RHOA phenotypes, we have
observed just two different phenotypes. Composite phe-
notype was present in 66% and atrophic phenotype in
34% of our patients. In female patients we have observed
in 78% of cases composite phenotype, while in male
patients we recorded the same radiographic phenotype
in 57% of cases.Wehave not observed osteophytic RHOA
phenotype in our patients with end-stage HOA.
Table 1. Association Analysis of IL1B SNP and IL1RN VNTR With Hip OA in the Croatian Population
IL1Bb
SNP
511
Allele Frequencya
p-Value
(OR) IL1Bc
SNP
511
Genotype Frequencya
p-Value
OR
(95% CI)
Patients,
n ¼ 518
Controls,
n ¼ 916
Patients,
n ¼ 259
Controls,
n ¼ 458
1 G 0.678 (351) 0.644 (590) 0.20 (1.16) 1/1 G/G 0.467 (121) 0.393 (180) 0.053 1.35 (0.98–1.86)
2 A 0.322 (167) 0.356 (326) 1/2 G/A 0.421 (109) 0.502 (230) 0.036 0.72 (0.52–0.99)
2/2 A/A 0.112 (29) 0.105 (48) 0.77
IL1RNb VNTR
Allele Frequencya
p-Value (OR) IL1RNc VNTR
Genotype Frequencya
p-Value
Patients,
n ¼ 164
Controls,
n ¼ 974
Patients,
n ¼ 232
Controls,
n ¼ 487
1/1 (4/4) 0.509 (118) 0.509 (248) 0.99
1 (4) 0.694 (322) 0.703 (685) 0.72 1/2 (4/2) 0.336 (78) 0.350 (173) 0.62
2 (2) 0.282 (131) 0.272 (265) 0.68 1/3 (4/5) 0.035 (8) 0.031 (15) 0.79
3 (5) 0.024 (11) 0.024 (23) 0.99 1/4 (4/3) 0 0.002 (1) 1.00
4 (3) 0 0.001 (1) 1.00 2/2 (2/2) 0.108 (25) 0.090 (44) 0.46
2/3 (2/5) 0.013 (3) 0.008 (4) 0.69
3/3 (5/5) 0 0.004 (2) 1.00
aFrequency (number). bAllele designations. The copy numbers of the VNTR are in the parenthesis. cGenotype designations. The copy
numbers of the VNTR are in the parenthesis.
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Wedid not notice signiﬁcant differences neither in the
severity grade nor in the kind of the OA of women and
men that carry genotypes 1–1/2–2 and 2–1/2–2, which
were found associate with protection and susceptibility
to OA, respectively. The sex differences were found sig-
niﬁcantly different in genotype 1–1/2–1.
DISCUSSION
The controversial role of the IL1 gene cluster in
affecting the genetic risk to HOAwas examined in seven
previous studies (Table 6) comprising at least three
ethnic populations (German, United Kingdom, and
Dutch).19–22,36,37,40
Moos et al.20 pointed to an association between the
IL1b polymorphism and the TNFahigh phenotype and
between the IL1Ra polymorphism and the TNFalow phe-
notype found in 61 (German) patients with end-stage hip
and knee OA who had undergone joint replacement
surgery. Previously, the same group38 suggested that
IL1bmay be more important than TNFa for the regula-
tion of cytokine and growth factor expression in articular
chondrocytes. Also, they suggested that the balance
between IL1b and IL1Ra regulates cartilage synthesis
and degradation. Their results suggested that the
deregulated cytokine expression promoted by the
respective genotypes leads to an enhanced expression
of matrix-degrading metalloproteinases and a reduced
synthesis of matrix components, and thus contributes to
the development of OA.39 Loughlin et al.19 genotyped
eight common polymorphic variants (seven SNPs and
one VNTR) located in the IL1 ligand gene cluster in a
study on 557 patients with hip and knee OA (almost 400
patients with HOA who had underwent THR) and
showed that the IL1 gene cluster is associated with
susceptibility to knee OA but not to HOA.
Table 2. Predicted IL1B–IL1RN Haplotype Frequencies and Haplotype Association Analysis in Hip OA
IL1B 511/IL1RN VNTR Total Population Controls (C) Patients (P) C vs. P
Haplotypesa
Other
Designationsb
E
(freq) SE N ¼ 1436
E
[Freq(0)]
SE
(0) N ¼ 918
E
[Freq(1)] SE (1) N ¼ 518 p-Value
1–1 G(4) 0.53238 0.00493 797 0.53060 0.00566 507 0.53555 0.00723 290 0.78
1–2 G(2) 0.09984 0.00480 111 0.08927 0.00557 62 0.11857 0.00683 49 0.065
1–3 G(5) 0.02302 0.00124 33 0.02280 0.00124 21 0.02342 0.00260 12 0.97
1–4 G(3) 0.00074 0.00017 1 0.00112 0.00019 1 0.00006 0.00033 0 1.00
2–1 A(4) 0.17039 0.00501 230 0.17957 0.00567 151 0.15411 0.00692 79 0.55
2–2 A(2) 0.17025 0.00498 261 0.17474 0.00564 175 0.16229 0.00689 86 0.25
2–3 A(5) 0.00336 0.00093 3 0.00187 0.00083 1 0.00600 0.00194 2 0.30
2–4 A(3) 0.00001 0.00010 0 0.00002 0.00015 0 0.00000 0.00000 0 —
E,estimated frequency;SE, standarderror. aIL1B511SNPmajorallele-1 orG; 2 orA-minor. bVNTRcopynumber inparenthesis.Hapotype
2–4 or A(3) was not found in our samples.
Table 3. IL1B–IL1RN Genotype Association Analysis in Hip OA
Genotypes
Controls (C),
N ¼ 459
Patients (P),
N ¼ 259
C vs. P,
p-Value
Odds Ratio
(95% CI) Association
1–1 1–1 122 87 0.047 1.4 (0.99–1.97) Trend to susceptibility
1–1 1–2 38 22 0.92
1–1 1–3 12 5 0.56
1–1 1–4 1 1.00
1–1 2–1 104 46 0.12
1–1 2–2 108 43 0.028 0.65 (0.43–0.97) Protection
1–2 1–2 4 7 0.06 3.16 (0.79–14.84) Trend to susceptibility
1–2 1–3 1 1.00
1–2 2–2 15 13 0.24
1–3 1–3 2 0.54
1–3 2–1 2 2 0.62
1–3 2–2 2 3 0.36
1–3 2–3 2 0.13
2–1 2–1 15 7 0.67
2–1 2–2 14 17 0.026 2.23 (1.03–4.88) Susceptibility
2–1 2–3 1 1.00
2–2 2–2 18 5 0.15
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Moxley et al.40 made IL1 region meta-analysis on
1,238 European-descent cases with various OA pheno-
types and 1,269 European-descent controls from four
study centers. For HOA, data from three centers showed
heterogeneity of the extended-risk-haplotype effect, two
haplotypes showing trend toward risk and another hap-
lotype showing protection. The heterogeneity fell partly
along control ascertainment lines, chieﬂy between con-
trols ascertained as spouses of arthroplasty patients and
controls identiﬁed through population radiographic sur-
vey. They concluded that meta-analysis data do not
conﬁrm but only suggest that some hand and HOA risk
could be associated with the IL1 region, particularly
centered in IL1B and possibly also IL1RN. However,
we believe that genetic studies from ethnically deﬁned
populations have a potential in identifying certain low-
risk genetic loci of complex hereditary diseases. Because
many genes could work together to convey a phenotypic
trait like, for example, a protection against OA, a
mutation in any of such genes would pose a threat to
their combined action thus lowering perhaps the robust-
ness of joints tomechanical injury. As variousmutations
in genes happen over time, mutations would tend to
separate and accumulate in different human popu-
lations. A particular humanpopulationwould then carry
a slightly different genetic risk to disease compared to
other populations. Hence, pooling data formeta-analysis
might blur such putative genetic connection and fail to
discover a variety of alleles conferring a low risk to OA.
For this reason we studied HOA in Croatian popu-
lation using two polymorphic markers from these two
loci. First, concerning allelic frequencies, we found that
the heterozygous (1/2 or G/A) genotype of IL1B (511
G>A) SNP was signiﬁcantly associated with the protec-
tion to HOA in Croatian population. Second, with regard
to haplotypic frequencies, none of the haplotypes were
signiﬁcantly associated with HOA in our study. Third, a
genotype comprising 2–1/2–2 haplotypes was found sig-
niﬁcantly associated with predisposition to HOA. On the
other hand, a genotype 1–1/2–2 was signiﬁcantly associ-
ated with protection to disease. Lastly, regarding the sex
bias, a haplotype 1–3 was signiﬁcantly associated with a
bias towards male population in acquiring HOA, and
genotype 1–1/2–1 was signiﬁcantly associated with a
bias to higher incidence of OA in females.
The two genotypes 1–1/2–2 and 2–1/2–2 had frequen-
cies of 21% and 4.3% in total population (16.6% and 6.6%
indiseasedand23.5%and3.1% in controls), respectively.
Thus, in approximately one-quarter of our studywehave
found markers associated with modulated risk of devel-
oping OA in this population. It is generally assumed that
the power of a case–control study is comparable to the
frequency of a genotype (or haplotype) in general popu-
lation. The higher the frequency, the higher the power it
Table 4. Hip OA: Male–Female Analysis of IL1B–IL1RN Genotypes
Genotypes
Female pt,
N ¼ 170
Male pt,
N ¼ 81
Female vs. Male pt,
p-Value
Odds Ratio
(95% CI) Association
1–1 1–1 61 25 0.43
1–1 1–2 14 7 0.91
1–1 1–3 1 4 0.039 0.11 (0.00–1.19) Male bias
1–1 2–1 36 8 0.028 2.45 (1.05–6.41) Female bias
1–1 2–2 28 14 0.87
1–2 1–2 5 2 1.00
1–2 2–2 9 4 1.00
1–3 2–1 1 0.32
1–3 2–2 1 2 0.24
2–1 2–1 3 4 0.22
2–1 2–2 10 7 0.42
2–2 2–2 2 3 0.33
Table 5. Hip OA: Sex Differences in IL1B–IL1RN Haplotype Analysis
IL1B 511/IL1RN VNTR
Total,
N ¼ 502
Female (F),
N ¼ 340
Male (M),
N ¼ 162
F vs. M,
p-Value OR (95% CI) AssociationHaplotypesa
Other
Designationsb
1–1 G(4) 284 201 83 0.096
1–2 G(2) 48 33 15 0.87
1–3 G(5) 9 2 7 0.006 0.13 (0.01–0.70) Male bias
2–1 A(4) 76 52 24 0.89
2–2 A(2) 85 52 33 0.16
aIL1B 511 SNP major allele-1 or G; 2 or A-minor. bVNTR copy number in parenthesis.
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would have, provided predisposition to OA has aMende-
lian character. Since OA belongs to a multifactorial non-
mendelian class of hereditary diseases, a particular
associated genotype (or haplotype) has potentially a
greater power in the search for predisposing factors than
anticipated by its frequency. For example, if our associ-
ated genotypes represent markers for putative risk fac-
tor(s), the latter couldbe spread to someextent over other
genotypes. Such genotypeswould appear not to be linked
to disease due to variability of typedmarkers and especi-
ally because of the lack of other hypothetical risk factors.
Therefore, the other genotypes might still harbor the
putative risk factors detected in genotypes 1–1/2–2
and 2–1/2–2 to an unknown extent.
In our study with 259 patients with end-stage HOA,
wehave observed only twoRHOAphenotypes. Apossible
explanation of these results is advanced stage of HOA
and high average age of our patients (almost 68 years).
Namely, in all our patients, superomedial and supero-
lateral JSNwas2, and that is the reason why we could
not classify any of those patients in the group of osteo-
phytic phenotype. The comparison of radiographic phe-
notype prior to surgery with genotyping indicated that
there were neither signiﬁcant difference in the severity
grade nor in the kind of the OA of women and men that
carry genotypes 1–1/2–2 and 2–1/2–2 which were found
associated with protection and susceptibility to OA,
respectively. In fact, there were equal numbers of either
sex in these haplotypes. The sex differences were found
signiﬁcantly different in genotype 1–1/2–1, which would
additionally point to complex susceptibility of the dis-
ease. In this group, women patients had more either
severe (grade 4) or atrophic kind of radiographic pheno-
type than men.
Our results conform to a view that a combination of
predisposing genetic factors may play a role in develop-
ing OA. The steps to be taken to decipher them in the
future would be the candidate gene approach based on
our current study and literature.41 These include genes
that regulate chondrocytes differentiation and survival
like the IL1 and IL4 cytokines, the secreted frizzled-
related protein 3 gene, and the asporin gene. It is import-
ant to establish their global relevance by genotyping OA
cohorts from different ethnic backgrounds. We would
also select the control population matching the age of
the cases allowing less conservative approach in the
analyses, which could help in identifying low-risk fac-
tors. In addition, stratiﬁcation along the severity grades
basedupon radiological proﬁlingmight help in searching
for new associations and susceptibility factors.
It is plausible that IL1 can affect the chondro-homeo-
stasis by aberrant dynamics of its production.Hence, it is
possible that an epigenetic event (like promoter methyl-
ation or histone acetylation) causing increased IL1 pro-
duction could raise the risk for developing OA. Whether
OA risk can bemodulated solely by epigenetic event(s) or
by a combination of genetic and epigenetic ones, remains
to be investigated.
Table 6. Associations of the IL1 Gene Cluster Polymorphisms With Hip OA
Study
Geographic
Ancestry
No. of Hip
OA Cases
Genotyped Markers of IL1 Region
AssociationIL1A IL1B IL1RN
Moos et al.20 German 61a — 3953 VNTR Positive
3953
Loughlin et al.19 United Kingdom 390 889 5810 VNTR Negative
31 9589
511 11100
Meulenbelt et al.21 Dutch 70 — 3953 VNTR Positive
511
3953 VNTR
Smith et al.22 United Kingdom 44 889 31 8006 Positive
511 11100
3953 VNTR
Meulenbelt et al.36 Dutch 70 889 31 8006 Positive
511 11100
Chapman et al.37 United Kingdom 370 — 3953 9589 Negative
511
Moxley et al.40 United Kingdom
and Dutch
252 889 3958 VNTR Some hip OA risk
could be associated
with the IL1 region
31 8006
511 11100
This work
(Jotanovic et al.)
Croatian 259 — 511 VNTR Positive
aPatients with end-stage knee or hip OA.
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Our study is the ﬁrst of this type in the Croatian
(Caucasian) population. Regarding the role of the IL1
gene cluster in affecting the genetic risk to HOA, our
results seem to be in agreement with studies by Moos
et al.20 and Meulenbelt et al.21, and are in disagreement
with the studybyLoughlin et al.19One of theweaknesses
of the study relates to the prevalence of HOA in the
general population (by radiography and clinical exam-
ination),which increases sharplywithage.Henceforth, a
group of seemingly healthy subjects at the age of 40 will
containmore of thosewhowill developHOAby the age of
70. The consequences of comparing the random popu-
lation controls (as we did) with OA patients with higher
age than controls are that thepotential differencesmight
have been blurred, and that the trends for associations
we observedmighthavebeenmorepronounced. Itmeans
that our results were on the conservative edge, and
perhaps that with an age-matched control group, our
results might have been more persuasive if not statisti-
cally signiﬁcant. Other weaknesses consider the group
size of patients, which if increased, could perhaps alle-
viate the possible type 1 error in statistical analyses
regarding the female–male ratio differences and/or
haplotype analyses. To our defense, our study is the
third largest amongst previously reported (Table 6).
The aggressiveness of treatment of the OA will hope-
fully depend on the molecular proﬁle of patients in the
future. If it would be such that it would point to a low risk
of progression, a treatmentwould be conservative. In the
case of a high risk of progression, the treatmentwould be
more aggressive. Wewould thus be able to treat patients
with new therapies including novel active small mol-
ecules, proteins, genes, and/or cells. If the nonsurgical
treatment of patients with OA will have failed or there
will have been progression of the disease, the molecular
proﬁle of patientswould behelpful in choosing the type of
surgical treatment for each patient individually, such as
selection of the most favorable type of prosthesis for an
individual requiring total joint replacement.42 The use of
molecular orthopedics will enable better prevention in
the future, various modalities of biological treatment,
more nonsurgical and less surgical treatment, fewer
surgical complications, and an individualized approach
to each patient with OA.
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